Dr. Christopher Lock, MD, PhD Advisor, Clinical Trials

Advisor

Christopher Lock

Education

Epsom College, Epsom, Surrey, UK

King’s College, University of London

Westminster Hospital Medical School, University of London

 

Scholarships and Honors

Ralph Gooding Chemistry Prize, Epsom College

Entrance Scholarship, Westminster Hospital Medical School

Barry Prize, Associate of King’s College Exam

Associate of King’s College (AKC), University of London

 

Previous Employment

Imperial Cancer Research Fund Laboratories (now Cancer Research UK), Guy’s and King’s College Hospital, University of London

Postdoctoral Scholar, Department of Microbiology and Immunology, Stanford University

Internship, Internal Medicine, Stanford University Medical Center

Neurology Residency, Stanford University Medical Center

Neuroimmunology Fellowship, Clinical Instructor, Stanford University Medical Center

Visiting Scientist, Inflammatory Diseases Unit (IDU), Roche Bioscience, Palo Alto

Neurologist, Palo Alto Medical Foundation, Sutter Health, Palo Alto / Fremont / Dublin

Research Scientist, Carantech Biosciences Inc., Mill Valley, CA

 

Current appointment

Clinical Associate Professor, Multiple Sclerosis and Neuroimmunology Clinic, Stanford University School of Medicine

Dr. Christopher Lock has dedicated his career to understanding the basic science underlying
multiple sclerosis and to caring for patients with MS. Over a career of 30 years at Stanford University and the Palo Alto Medical Foundation as a clinician and basic science researcher, Dr. Lock has published in prestigious journals such as the Nature and Science, taught medical students, neurology residents and fellows, worked at a pharmaceutical start-up, and has been an investigator on multiple grants and clinical trials focused on both treatment and the basic science of MS. 

 

Publications: https://orcid.org/0000-0002-4087-5894